thiazoles has been researched along with thienopyrimidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, P; Buttar, D; Campbell, L; Curwen, J; Emery, SC; Griffen, AM; Hassall, L; Hayter, BR; Jones, CD; Luke, RW; McCoull, W; Mellor, M; Swain, ML; Tucker, JA | 1 |
Abdou, AM; El-Dash, Y; Elzayat, E; Hassan, RA | 1 |
2 other study(ies) available for thiazoles and thienopyrimidine
Article | Year |
---|---|
Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.
Topics: Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Receptor, TIE-2; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2009 |
Novel thienopyrimidine-aminothiazole hybrids: Design, synthesis, antimicrobial screening, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and VEGFR-2 inhibition.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2 | 2021 |